Records containing: Influenza

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2014-02-07
  A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years
• CLINICAL_TRIALS study record update · 2014-02-04
  Cluster-randomised, Double-Blind, Placebo-Controlled Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections in Sheltered Accommodation (ViDiFlu)
• CLINICAL_TRIALS study record update · 2014-02-03
  A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
• CLINICAL_TRIALS study record update · 2014-01-29
  A Phase 3, Open Label, Uncontrolled, Multicenter Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, Influenza Vaccine (Fluvirin®), Formulation 2012/2013, When Administered to Adult and Elderly Subjects
• CLINICAL_TRIALS study record update · 2014-01-27
  A Phase 3 Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture (Optaflu®), Formulation 2012/2013, When Administered to Adult and Elderly Subjects
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2014-01-24
  A Phase I, Observer-Blind, Randomized, Single-Center Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines in Healthy Adults Aged 18 to 39 Years.
• CLINICAL_TRIALS study record update · 2014-01-24
  A Phase Ib, Randomized, Observer-Blind, Multicenter, Factorial-Design Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Injections of Trivalent Inactivated Influenza Vaccine With or Without a Second Influenza B Strain in Combination With or Without One of Three Different Doses of Adjuvant in Healthy Children, Aged 6 to <36 Months
• CLINICAL_TRIALS study record update · 2014-01-17
  Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation (Intramuscular Route)
• CLINICAL_TRIALS study record update · 2014-01-17
  Immunogenicity and Safety of the Influenza Vaccine (Split Virion, Inactivated), Northern Hemisphere 2009-2010 Formulation (Intramuscular Route)
• CLINICAL_TRIALS study record update · 2014-01-17
  Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2006-2007 Formulation (Intramuscular Route)
• CLINICAL_TRIALS study record update · 2014-01-17
  Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2007-2008 Formulation (Intramuscular Route)
• CLINICAL_TRIALS study record update · 2014-01-14
  Immunogenicity and Safety of Multiple Formulations of an Intramuscular Inactivated, Split Virion Swine-origin A/H1N1 Influenza Vaccine With and Without Adjuvant in Healthy European Adult and Elderly Subjects
• CLINICAL_TRIALS study record update · 2014-01-14
  Immunogenicity and Safety of the Influenza Vaccine (Split Virion, Inactivated), Northern Hemisphere 2009-2010 Formulation (Intradermal Route)
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00545701
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00383539
• CLINICAL_TRIALS study record update · 2014-01-14
  Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in European Children
• CLINICAL_TRIALS study record update · 2014-01-14
  Bridging Study on Safety and Immunogenicity of an Intramuscular Inactivated, Split Virion Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India
• CLINICAL_TRIALS study record update · 2014-01-14
  Immunogenicity of the Inactivated Split-Virion Influenza Vaccine Administered by the Intradermal Route in Renal Transplant Subjects
• CLINICAL_TRIALS study record update · 2014-01-14
  Immunogenicity and Safety of Multiple Formulations of an Intramuscular Inactivated, Split Virion Swine-origin A/H1N1 Influenza Vaccine With and Without Adjuvant in Healthy European Subjects Aged 6 to 35 Months
• CLINICAL_TRIALS study record update · 2014-01-14
  Immunogenicity and Safety of Multiple Formulations of an Intramuscular Inactivated, Split Virion Swine-Origin A/H1N1 Influenza Vaccine With and Without Adjuvant in Healthy European Subjects Aged 3 to 17 Years
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00491985
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00296829
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00258934
• CLINICAL_TRIALS study record update · 2014-01-14
  Immunogenicity of the Intramuscular Inactivated, Split Virion Swine-origin A/H1N1 Influenza Vaccine Without Adjuvant in Healthy Adult Subjects
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00383526